08.31.07
Posted in Uncategorized at 8:00 pm by Cancer / Oncology News From Medical News Today
Presidential candidates Sen. Sam Brownback (R-Kan.) and former Arkansas Gov. Mike Huckabee (R) on Tuesday during the second day of a cancer forum in Cedar Rapids, Iowa, discussed issues related to the disease and health care, the [click link for full article]
Permalink
Posted in Uncategorized at 4:00 pm by Cancer / Oncology News From Medical News Today
A leading epidemiologist has attacked Swedish research that looked at inequalities in patients' access to cancer drugs across Europe and the world. [click link for full article]
Permalink
Posted in Uncategorized at 4:00 pm by Cancer / Oncology News From Medical News Today
In response to the recent final decision by NICE on the use of Velcade for cancer patients with myeloma, the bone marrow cancer, charities Myeloma UK, Cancerbackup and Leukaemia CARE issue the following response: The long awaited decision on Velcade has resulted in a positive approval of the treatment, but many patients will now be ineligible to receive it after a change in the guidance since the preliminary ruling in June. [click link for full article]
Permalink
Posted in Uncategorized at 3:00 am by Cancer / Oncology News From Medical News Today
Among a growing number of Americans seeking general health information and information about cancer, the Internet remains a frequent first source, even though the public's trust in online material about health has declined, reports a government study. At the same time, consumers voiced greater confidence in information received from healthcare professionals. [click link for full article]
Permalink
Posted in Uncategorized at 3:00 am by Cancer / Oncology News From Medical News Today
BC Cancer Agency researchers, led by Drs. Stephen Lam and Wan Lam, have discovered new evidence that explains why former smokers are still susceptible to lung cancer after they have stopped smoking for many years.Published today in the online journal BMC Genomics, the study shows that in former smokers, some genes associated with tobacco smoking return to levels similar to people who never smoked, while other genes appear to be permanently damaged. [click link for full article]
Permalink
Posted in Uncategorized at 2:00 am by Cancer / Oncology News From Medical News Today
As part of its continued effort to give back to the cancer communities in the cities visited during its annual scientific meeting, the Fairfax, Virginia-based American Society for Therapeutic Radiology and Oncology (ASTRO) is partnering with Vital Options International to raise awareness of cancer survivorship. Vital Options International is a not-for-profit cancer communications, support and advocacy organization with a mission to facilitate a global cancer dialogue. [click link for full article]
Permalink
Posted in Uncategorized at 2:00 am by Cancer / Oncology News From Medical News Today
Bayer Schering Pharma announced that the Singapore Health Sciences Authority (HSA) has approved Nexavar? (Sorafenib) tablets for the treatment of patients with advanced renal cell carcinoma (ARCC), or advanced kidney cancer. [click link for full article]
Permalink
Posted in Uncategorized at 1:00 am by Cancer / Oncology News From Medical News Today
A new website has been launched to facilitate recruitment of patients to OVATURE (OVArian TUmor REsponse), a Phase III clinical trial of an investigational ovarian cancer drug phenoxodiol. The goal of http://www.OVATUREtrial.com is to inform ovarian cancer patients about the OVATURE trial, which is actively recruiting patients, and to provide more information about the trial and the investigational drug phenoxodiol. [click link for full article]
Permalink
Posted in Uncategorized at 1:00 am by Cancer / Oncology News From Medical News Today
YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, announced that its wholly-owned US subsidiary, YM BioSciences USA Inc. [click link for full article]
Permalink
Posted in Uncategorized at 1:00 am by Cancer / Oncology News From Medical News Today
Novocell Inc., a stem cell engineering company, announced research findings that for the first time identify two prominent cancer cell signaling pathways as essential for the efficient proliferation and self-renewal of human embryonic stem cells (hESCs). The findings were prepublished online August 29, 2007 in Blood First Edition Paper titled "Self-Renewal of Human Embryonic Stem Cells Requires Insulin-like Growth Factor-1 Receptor and ERBB2 Receptor Signaling. [click link for full article]
Permalink
« Previous entries
